Načítá se...
Biases in evaluating the safety and effectiveness of drugs for covid-19: designing real-world evidence studies
The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to an unprecedented effort to generate real-world evidence on the safety and effectiveness of various treatments. A growing number of observational studies evaluating t...
Uloženo v:
| Vydáno v: | Am J Epidemiol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7929453/ https://ncbi.nlm.nih.gov/pubmed/33564823 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/aje/kwab028 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|